ALKs dedicated research and development has shown that allergy immunotherapy addresses the underlying cause of the allergy rather than just treating the symptoms. With its latest product, ALK has become the first and only company to develop and launch a house dust mite SLIT-tablet which is indicated for usage in allergic rhinitis.